AffyImmune Therapeutics

Newton, United States

AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.

$20.0M raised

Oct 2021

Series A

Biopharma Biotechnology Life Science

Top Investors

ORI Capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about AffyImmune Therapeutics

How much funding has AffyImmune Therapeutics raised?

AffyImmune Therapeutics has raised $20.0M in total funding. The most recent round was Series A. The last funding was announced in October 2021.

Who are AffyImmune Therapeutics's investors?

AffyImmune Therapeutics's investors include ORI Capital.

Where is AffyImmune Therapeutics headquartered?

AffyImmune Therapeutics is headquartered in Newton, United States.

What does AffyImmune Therapeutics do?

AffyImmune Therapeutics is a biopharmaceutical company developing genetically engineered immune cells to fight cancer.

What stage is AffyImmune Therapeutics at?

AffyImmune Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 7, 2021.

MLA

"AffyImmune Therapeutics — Funding & Investors." VCBacked, October 7, 2021, https://www.vcbacked.co/company/affyimmune-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). AffyImmune Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/affyimmune-therapeutics

Wikipedia (cite web)

{{cite web |title=AffyImmune Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/affyimmune-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 7, 2021.